Pharmacotherapy for prevention of post-traumatic stress disorder

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Ipser, Jonathan C ^a   Seedat, S ^b   Stein, D J ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE; BROFAROMINE; BROMAZEPAM; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; INOSITOL; LITHIUM; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; PINDOLOL; PRAZOSIN; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; DATA ANALYSIS; DEPRESSION; DRUG EFFICACY; HUMAN; INFORMATION PROCESSING; METHODOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; REVIEW; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 37649029676     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006239     Document Type: Review

References (68)

1. Alderson P, Green S, Higgins JP. Assessment of study quality. In: AldersonP, GreenS, HigginsJPT editor(s). Cochrane Reviewers' Handbook 4.2.1 [updated December] Section 8;. Chichester, UK: John Wiley & Sons, Ltd., 2004.
2. Als-Nielsen B, ChenW, Gluud C, Kjaergard LL. Association of fund-ing and conclusions in randomized drug trials - A reection of treat-ment effect or adverse events?. JAMA 2003;290:921-8.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
4. Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry 2003;183:498-506.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561- 71.
6. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report. Journal of Clinical Psychiatry 2002;63:15-20.
7. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a clinician-administered PTSD scale. Journal of Traumatic Stress 1995;8(1):75-90.
8. Boris NW, Ou AC, Singh R. Preventing post-traumatic stress disorder after mass exposure to violence. Biosecurity and bioterrorism 2005;3(2):154-63.
9. Bremner JD, Vermetten E. Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder. Annals of the New York Academy of Science 2004;1032:154-7.
10. Breslau N, Davis GC, Andreski P. Traumatic events and post traumatic stress disorder in an urban population of young adults. Archives of General Psychiatry 1991;48:216-22.
11. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. Journal of Consulting and Clinical Psychology 2000;68(5):748-66.
12. Brunello N, Davidson JR, Deahl M, Kessler RC, Mendlewicz J, Racagni G, et al. Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology 2001;43(3):150-62.
13. Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R. Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. American Journal of Psychiatry 1999;156(11):1780-6.
14. Bryant RA. Early predictors of posttraumatic stress disorder. Biolog-ical Psychiatry 2003;53:789-95.
15. Bryant RA, Moulds ML, Guthrie RM, Nixon RD. The additive benefit of hypnosis and cognitive-behavioral therapy in treating acute stress disorder. Journal of Consulting and Clincal Psychology 2005;73(2):334-40.
16. Canive JM, Lewine JD, Orrison WW Jr, Edgar CJ, Provencal SL, Davis JT, et al. MRI reveals gross structural abnormalities in PTSD. Annals of the New York Academy of Science 1997;821:512-5.
17. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disiorder. Archives of General Psychiatry 1993;50(4):294-306.
18. Connor KM, Davidson JR. The role of serotonin in posttraumatic stress disorder: Neurobiology and pharmacotherapy. CNS Spectrums 1998;3(7S2):43-51.
19. Davidson JR, Hughes D, Blazer DG, George LK. Posttraumatic stress disorder in the community : an epidemiological study. Psychological Medicine 1991;21(3):713-21.
20. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, DaveySG, AltmanDG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
21. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in medicine 2002;21(11):1575-600.
22. Deeks J, Higgins J, Altman D. Cochrane Reviewers' Handbook 4.2.1 [updated December 2003]. In: AldersonP, GreenS, HigginsJ editor (s). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd., 2003.
23. Dickersin K, Min YI, Meinert CL. Factors inuencing the publication of research results : follow-up of applications submitted to two substantial review boards. JAMA 1992;267(3):374-8.
24. Eaterbrook PJ, Berline JA, Gopaian R, Matthews DR. Publication bias in clinical research. Lancet 1991;337(8746):867-72.
25. Egger M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
26. Egger M, Smith GD, Minder C. Author's reply. BMJ 1998;316:470-1.
27. Ehlers A, Clark DM. A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy 2000;38:319-45.
28. Elbourne ER, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: Methodological issues. International Journal of Epidemiology 2002;31:140-9.
29. Foa EB, Hearst-Ikeda D, Perry KJ. Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. Journal of Consulting and Clincal Psychology 1995;63(6):948-55.
30. Friedman MJ. Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment. Psychiatric Clinics of North America 2002;25(2):427-41.
31. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. Journal of Clinical Psychiatry 1996;57(9):390-4.
32. Guy W. ECDEU assessment manual for psychopharmacology. Washington, DC: U.S. National Institute of Health, 1976.
33. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50-5.
34. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
35. Hebert MA, Potegal M, Moore T, Evenson AR, Meyerhoff JL. Diazepam enhances conditioned defeat in hamsters (Mesocricetus auratus). Pharmacology, Biochemistry and Behavior 1996;55(3):405-13.
36. Higgins JT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(6):557-60.
37. Hobbs M, Mayou R, Harrison B, Worlock P. A randomised controlled trial of psychological debriefing for victims of road traffic accidents. BMJ 1996;313(7070):1438-9.
38. Hull A. Neuroimaging findings in post-traumatic stress disorder. British Journal of Psychiatry 2002;181:102-10.
39. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 1995;52(12):1048-60.
40. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005;62(2):593-602.
41. Lumley LA, Charles RF, Charles RC, Hebert MA, Morton DM, Meyerhoff JL. Effects of social defeat and of diazepam on behavior in a resident-intruder test in male DBA/2 mice. Pharmacology, Biochemistry and Behavior 2000;67(3):433-47.
42. Mayou RA, Ehlers A, Hobbs M. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial. British Journal of Psychiatry 2000;176:589-93.
43. McCleery JM, Harvey AG. Integration of psychological and biological approaches to trauma memory: implications for pharmacological prevention of PTSD. Journal of Traumatic Stress 2004;17(6):485-96.
44. Mellman TA, Bustamante V, David D, Fins AI. Hypnotic medication in the aftermath of trauma. Journal of Clinical Psychiatry 2002;63(12): 1183-4.
45. Moncrieff J, Churchill R, Drummond DC, McGuire H. Development of a quality assessment instrument for trials of treatments for depression and neurosis. International Journal of Methods in Psychiatric Research 2001;10(3):126-33.
46. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
47. Morgan CA 3rd, Krystal JH, Southwick SM. Toward early pharmacological posttraumatic stress intervention. Biological Psychiatry 2003;53(9):834-43.
48. Guideline Development Group. Post-traumatic stress disorder: The management of PTSD in adults and children in primary and secondary care. Vol. 26, London: Gaskell and the British Psychological Society, 2005.
49. Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: A meta-analysis. Psychological Bulletin 2003;129(1):52-73.
50. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry 2002;51:189-92.
51. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2005.
52. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 2002;31:150-3.
53. Rose S, Bisson J, Wessely S. Psychological debriefng for preventing post traumatic stress disorder (PTSD). In: The Cochrane Database of Systematic Reviews, 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
54. Ruzek J, Watson P. Early intervention to prevent PTSD and other trauma-related problems. PTSD Research Quarterly 2001;12(4):1-7.
55. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatry disorders. Archives of General Psychiatry 2000;57:925-35.
56. Schelling G, Stoll C, Kapfhammer HP, Rothenhausler HB, Krauseneck T, Durst K, et al. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Critical CareMedicine 1999;27(12):2678-83.
57. Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhausler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biological Psychiatry 2001;50(12):978-85.
58. Schelling G, Kilger E, Roozendaal B, de Quervain DJ, Briegel J, Dagge A, et al. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biological Psychiatry 2004;55(6):627-33.
59. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented in abstracts. A meta-analysis. JAMA 1994;272(2):158-62.
60. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. International Clinical Psychopharmacology 1996;11 Suppl 3:89-95.
61. Solomon SD, Davidson JR. Trauma: Prevalence, impairment, service use, and cost. Journal of Clinial Psychiatry 1997;58 Suppl 5:1-11.
62. Spitzer R, Williams J, Gibbons M. Instructional manual for the structured clinical interview for DSM-IV. New York, NY: New York State Psychiatric Institute., 1996.
63. Stein DJ, Ipser J, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). In: The Cochrane Database of Systematic Reviews, 1, 2006. Chichester, UK: John Wiley & Sons, Ltd.
64. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309(6965):1351-5.
65. Turpin G, Downs M, Mason S. Effectiveness of providing self-help information following acute traumatic injury: randomised controlled trial. British Journal of Psychiatry 2005;187:76-82.
66. Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biological Psychiatry 2003; 54(9):947-9.
67. Verbeke M, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, NY: Springer, 2000.
68. Yehuda R, McFarlane AC. Conict between current knowledge about posttraumatic stress disorder and its original conceptual basis. American Journal of Psychiatry 1995;152(12):1705-13.